Results 101 to 110 of about 40,842 (165)
Some of the next articles are maybe not open access.

“Selective” serotonin 5-HT2A receptor antagonists

Biochemical Pharmacology, 2022
Blockade of the serotonin 5-HT2A G protein-coupled receptor (5-HT2AR) is a fundamental pharmacological characteristic of numerous antipsychotic medications, which are FDA-approved to treat schizophrenia, bipolar disorder, and as adjunctive therapies in major depressive disorder.
Austen B, Casey   +3 more
openaire   +2 more sources

Clozapine—A serotonin antagonist?

Pharmacology Biochemistry and Behavior, 1984
The effect of clozapine on the central serotonergic transmission system was studied by investigation of open-field motility of rats after microinjection of drugs into nucleus accumbens and median raphe nucleus. Previous work has shown that LSD in low doses potentiates apomorphine-induced hypermotility and that this LSD effect is induced by a serotonin ...
H, Fink, R, Morgenstern, W, Oelssner
openaire   +2 more sources

Effects of serotonin and serotonin antagonists on chick embryogenesis

Wilhelm Roux's Archives of Developmental Biology, 1979
Serotonin and some selected substances known to interfere with its formation (diethyldithiocarbamate) and function (Catron®, 5-methyltryptamine, promethazine) were tested for their ability to affect chick embryo morphogenesis during the first 48 h of development.
Kjell, Palén   +2 more
openaire   +2 more sources

SEROTONIN ANTAGONISTS

Australian and New Zealand Journal of Medicine, 1984
The realisation that serotonin plays a role not only in the carcinoid syndrome but also in migraine, nociception, dumping syndrome, vascular disease and hypertension, has led to an enormous amount of activity in search of serotonin antagonists. Numerous such pharmacological agents have been identified but only few have found their way into clinical use.
openaire   +2 more sources

Serotonin antagonists and vascular protection

Cardiovascular Drugs and Therapy, 1990
There is very suggestive evidence for a role of serotonin release from platelets in the mechanisms for platelet aggregation, arterial thrombosis, and arterial spasm. These effects are mediated via the 5HT2 receptor and are specifically antagonized by ketanserin.
openaire   +2 more sources

Granisetron: The Second Serotonin-Receptor Antagonist

Annals of Pharmacotherapy, 1995
Objective: To review the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of granisetron, focusing on critical analysis of published clinical trials and comparison with other antiemetic agents, including ondansetron. Data Sources: MEDLINE (1966–1995) and CANCERLIT (1991–1995) searches of English-language literature using the terms
V R, Adams, A W, Valley
openaire   +2 more sources

Hyperglycemic properties of serotonin receptor antagonists

Life Sciences, 1991
Several serotonin (5-HT) receptor antagonists with varying specificities for the 5-HT receptor types, were studied with regard to their effects on blood glucose levels in mice. The non-selective antagonists, metergoline and methysergide, proved to be hyperglycemic at doses commonly used to antagonize 5-HT receptors. In contrast, ritanserin (a 5-HT2 and
K M, Wozniak, M, Linnoila
openaire   +2 more sources

Serotonin Antagonism and Serotonin Antagonists in Pregnancy: Role of Ketanserin

Obstetrical & Gynecological Survey, 2000
Most agree that antihypertensive medication should be used to treat severe hypertension during pregnancy, but its role in patients with mild to moderate disease is debated. None of the regularly used drugs is completely safe for mother and fetus. Ketanserin decreases systolic and diastolic blood pressure in nonpregnant patients with acute and chronic ...
D W, Steyn, H J, Odendaal
openaire   +2 more sources

Home - About - Disclaimer - Privacy